JP2018528441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528441A5 JP2018528441A5 JP2018533586A JP2018533586A JP2018528441A5 JP 2018528441 A5 JP2018528441 A5 JP 2018528441A5 JP 2018533586 A JP2018533586 A JP 2018533586A JP 2018533586 A JP2018533586 A JP 2018533586A JP 2018528441 A5 JP2018528441 A5 JP 2018528441A5
- Authority
- JP
- Japan
- Prior art keywords
- capture reagent
- biomarker
- aptamers
- antibodies
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000090 biomarker Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920002395 Aptamer Polymers 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 102000004965 antibodies Human genes 0.000 description 1
- 108090001123 antibodies Proteins 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
Description
前記バイオマーカー値を検出する段階は、インビトロ(in vitro)での検定を行う段階を含むことができる。 The step of detecting the biomarker value can include a step of performing an in vitro test.
前記インビトロ(in vitro)での検定は、前記バイオマーカータンパク質それぞれに対応する1つの捕捉試薬を含むことができ、前記方法は、アプタマー、抗体及び核酸プローブからなる群より少なくとも1つの捕捉試薬を選択する段階を更に含むことができる。 The in vitro assay can include one capture reagent corresponding to each of the biomarker proteins, the method selecting at least one capture reagent from the group consisting of aptamers, antibodies and nucleic acid probes. Further steps can be included.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2015/009552 WO2017043679A1 (en) | 2015-09-11 | 2015-09-11 | Protein biomarker panel for detecting non-small cell lung cancer and method for diagnosing a non-small cell lung cancer by the use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018528441A JP2018528441A (en) | 2018-09-27 |
JP2018528441A5 true JP2018528441A5 (en) | 2021-03-25 |
JP6857185B2 JP6857185B2 (en) | 2021-04-14 |
Family
ID=58239995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018533586A Active JP6857185B2 (en) | 2015-09-11 | 2015-09-11 | Protein biomarker panel for non-small cell lung cancer diagnosis and non-small cell lung cancer diagnostic method using this |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6857185B2 (en) |
KR (2) | KR102078310B1 (en) |
CN (1) | CN108026584B (en) |
WO (1) | WO2017043679A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI758670B (en) * | 2018-12-24 | 2022-03-21 | 奎克生技光電股份有限公司 | Health risk assessment method |
CN110333341A (en) * | 2019-07-04 | 2019-10-15 | 浙江理工大学 | A method of silk fabric cultural relics sample is identified based on protein biochip technology |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002053592A1 (en) * | 2000-12-28 | 2002-07-11 | Shionogi & Co., Ltd. | Novel polypeptide and dna thereof |
US7888051B2 (en) * | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
WO2010105235A2 (en) * | 2009-03-12 | 2010-09-16 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
ES2703363T3 (en) * | 2008-02-01 | 2019-03-08 | Massachusetts Gen Hospital | Use of microvesicles in the diagnosis and prognosis of brain tumors |
JP5701212B2 (en) * | 2008-09-09 | 2015-04-15 | ソマロジック・インコーポレーテッド | Lung cancer biomarkers and their use |
WO2011109440A1 (en) * | 2010-03-01 | 2011-09-09 | Caris Life Sciences Luxembourg Holdings | Biomarkers for theranostics |
SG168431A1 (en) * | 2009-07-23 | 2011-02-28 | Univ Singapore | Cancer biomarker and the use thereof |
EP2462164A2 (en) * | 2009-08-04 | 2012-06-13 | Biosystems International SAS | Lung cancer biomarkers |
CN104777313B (en) * | 2010-07-09 | 2017-09-26 | 私募蛋白质体公司 | Lung cancer biomarkers and application thereof |
JP2014519340A (en) * | 2011-06-16 | 2014-08-14 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス.アー.エール.エル. | Biomarker compositions and methods |
CA2844671A1 (en) * | 2011-08-08 | 2013-02-14 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarker compositions and methods |
WO2013033019A1 (en) * | 2011-08-31 | 2013-03-07 | University Of Utah Research Foundation | Methods for determining the integrity of a biological sample |
SG11201400375SA (en) * | 2011-10-24 | 2014-04-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
MX338162B (en) | 2011-10-24 | 2016-04-04 | Hewlett Packard Development Co | Fluid ejection devices and methods thereof. |
WO2013152989A2 (en) * | 2012-04-10 | 2013-10-17 | Eth Zurich | Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer |
-
2015
- 2015-09-11 JP JP2018533586A patent/JP6857185B2/en active Active
- 2015-09-11 WO PCT/KR2015/009552 patent/WO2017043679A1/en active Application Filing
- 2015-09-11 CN CN201580083066.4A patent/CN108026584B/en active Active
- 2015-09-11 KR KR1020187007151A patent/KR102078310B1/en active IP Right Grant
- 2015-09-11 KR KR1020207004010A patent/KR102087373B1/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201816522D0 (en) | Methods and reagents for analysing nucleic acids from single cells | |
WO2017055487A3 (en) | A METHOD FOR DIAGNOSING A DISEASE BY DETECTION OF circRNA IN BODILY FLUIDS | |
EP3480310A4 (en) | Probe for nucleic acid enrichment and capture, and design method thereof | |
BR112018002173B8 (en) | Systems and methods using magnetic response sensors to determine a genetic trait | |
CA2873099C (en) | Aptamer-based multiplexed assays | |
JP2014132019A5 (en) | ||
EP3636769A4 (en) | Sample nucleic acid measurement test kit, reagent, and application thereof | |
WO2015095355A3 (en) | Detection of an antibody against a pathogen | |
EP3216852A4 (en) | Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component | |
BR112017022329A2 (en) | methods for detecting agglutination and compositions for use in practice thereof | |
IT201600073964A1 (en) | NANO SWITCH BASED ON NUCLEOTIDES AND METHODS FOR DETECTING ANTIBODIES AND OTHER ANALYTES | |
BR112014026440A2 (en) | assays, methods and apparatus for assessing rna disruption | |
WO2013166444A3 (en) | Biomarker analysis using scodaphoresis | |
WO2015054700A3 (en) | Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof | |
WO2015023503A3 (en) | Compositions and methods for multimodal analysis of cmet nucleic acids | |
JP2018528441A5 (en) | ||
EP3557259A3 (en) | Methods and arrays for use in the same | |
WO2015068075A3 (en) | Detection of tau | |
WO2014160237A3 (en) | Methods of prognosing preeclampsia | |
SG10201907690TA (en) | Device and method for detecting target molecules | |
EP2998408A4 (en) | Method for obtaining epigenetic cell information, method for determining cell characteristics, method for assessing drug sensitivity or selecting drug or immunotherapeutic agent variety, disease diagnosis method, self-replicating vector, assay kit, and analysis device | |
WO2014145243A3 (en) | High resolution melting analysis assay for the detection of viral dna | |
WO2015038987A3 (en) | System and method for whole-animal high-throughput compound screening | |
MX2016017048A (en) | Collaborative enzyme enhanced reactive (ceer) immunoassay using flow cytometry. | |
AR095089A1 (en) | VIRUS JC DNA DETECTION TEST |